Skip to content

Aviation Portable Oxygen Delivery System

Aviation Portable Oxygen Delivery System Based on Pneumatic Pulse Technology

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03425409
Enrollment
0
Registered
2018-02-07
Start date
2018-09-01
Completion date
2018-10-01
Last updated
2018-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxygen Delivery Systems at Altitude

Brief summary

This study aims to investigate dose based oxygen delivery vs. continuous flow of oxygen during simulated altitude conditions as would be experienced after a loss of pressure during commercial aircraft flight. Testing will be performed at rest and during light exercise at a simulated altitude of 15,000 feet in a hypobaric chamber. Performance of the two oxygen delivery systems will be compared using oxygen saturation determined by pulse oximetry.

Interventions

DEVICEIntegra Pulse Portable- Continuous flow

4 liters per minute oxygen flow

DEVICEIntegra Pulse Portable- Pneumatic pulsed flow

Oxygen flow determined by test device

Sponsors

Odessey II Solutions
CollaboratorUNKNOWN
Duke University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy volunteers

Exclusion criteria

* smoking * pregnancy * sickle cell trait * cardiovascular or pulmonary disease * significant ear or sinus problems that would prevent equalization during pressure change * estimated VO2peak \<35 mL/kg per minute (males) or \<30 mL/kg per minute (females)

Design outcomes

Primary

MeasureTime frameDescription
Device performance, as measured by SpO2one minuteThe same subject must complete both oxygen delivery system exposures for the data to be used in system performance analysis. Equivalence of the two oxygen delivery systems will be defined as the lack of statistically significant difference (N=20) in SpO2 during the last minute of exercise between the pulse and continuous flow oxygen delivery systems. Average minimum SpO2 over the last minute of the test period will be reported.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026